Cargando…
Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569492/ https://www.ncbi.nlm.nih.gov/pubmed/34741117 http://dx.doi.org/10.1038/s41375-021-01457-1 |
_version_ | 1784594651733295104 |
---|---|
author | Kozak, Kathryn E. Ouyang, Linda Derkach, Andriy Sherman, Alexandra McCall, Susan J. Famulare, Christopher Chervin, Jordan Daley, Ryan J. Morjaria, Sejal Mauro, Michael J. Rampal, Raajit K. |
author_facet | Kozak, Kathryn E. Ouyang, Linda Derkach, Andriy Sherman, Alexandra McCall, Susan J. Famulare, Christopher Chervin, Jordan Daley, Ryan J. Morjaria, Sejal Mauro, Michael J. Rampal, Raajit K. |
author_sort | Kozak, Kathryn E. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8569492 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85694922021-11-05 Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines Kozak, Kathryn E. Ouyang, Linda Derkach, Andriy Sherman, Alexandra McCall, Susan J. Famulare, Christopher Chervin, Jordan Daley, Ryan J. Morjaria, Sejal Mauro, Michael J. Rampal, Raajit K. Leukemia Letter Nature Publishing Group UK 2021-11-05 2021 /pmc/articles/PMC8569492/ /pubmed/34741117 http://dx.doi.org/10.1038/s41375-021-01457-1 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Letter Kozak, Kathryn E. Ouyang, Linda Derkach, Andriy Sherman, Alexandra McCall, Susan J. Famulare, Christopher Chervin, Jordan Daley, Ryan J. Morjaria, Sejal Mauro, Michael J. Rampal, Raajit K. Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines |
title | Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines |
title_full | Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines |
title_fullStr | Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines |
title_full_unstemmed | Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines |
title_short | Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines |
title_sort | serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with sars-cov-2 spike protein messenger rna (mrna) vaccines |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569492/ https://www.ncbi.nlm.nih.gov/pubmed/34741117 http://dx.doi.org/10.1038/s41375-021-01457-1 |
work_keys_str_mv | AT kozakkathryne serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines AT ouyanglinda serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines AT derkachandriy serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines AT shermanalexandra serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines AT mccallsusanj serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines AT famularechristopher serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines AT chervinjordan serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines AT daleyryanj serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines AT morjariasejal serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines AT mauromichaelj serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines AT rampalraajitk serumantibodyresponseinpatientswithphiladelphiachromosomepositiveornegativemyeloproliferativeneoplasmsfollowingvaccinationwithsarscov2spikeproteinmessengerrnamrnavaccines |